ICUCW

Insider Trades

Name	Value	Action	Price	Current Price
Baird Jennifer ADirector $9874.2k shares BuyDec 19, 2025 $0.2351 --
Messinger MichaelChief Financial Officer $5.1k14.5k shares BuyDec 9, 2025 $0.3516 --
Van Heel KennethDirector $8.6k10k shares BuyAug 27, 2025 $0.8565 --
Van Heel KennethDirector $22k25k shares BuyAug 26, 2025 $0.8899 --
Chung KevinChief Medical Officer $8.0k10k shares BuyAug 22, 2025 $0.80 --
Baird Jennifer ADirector $4.2k10k shares BuyJun 30, 2025 $0.4174 --

News

seekingalpha.comSeaStar Medical Holding Corporation (ICU) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 13

Trade ICUCW

About SeaStar Medical Holding Corporation

Based in Denver, Colorado, SeaStar Medical Holding Corporation operates as a medical device company. Its primary mission is to develop innovative therapies and services designed to combat hyperinflammation and cytokine storm, particularly in critically ill individuals. The company specializes in advancing and bringing to market extracorporeal treatments. These therapies are engineered to specifically target the immune "effector cells" that fuel widespread systemic inflammation, which is known to cause direct tissue damage and unleash a cascade of pro-inflammatory cytokines, leading to dysregulated immune responses. SeaStar Medical's product pipeline extends across diverse therapeutic domains. These include both pediatric and adult acute kidney injury, particularly when patients are undergoing continuous renal replacement therapy (CRRT); cardiorenal syndrome observed in cases of congestive heart failure, whether or not an LVAD is present; myocardial stunning associated with end-stage renal disease; and hepatorenal syndrome.

CEO: Eric Schlorff
IPO Date: Mar 18, 2021

Market Data

Open: $0.0375
High: $0.0375
Low: $0.0162
Volume: 7.1K
Avg Volume: 89.6K
52W High: $0.0375
52W Low: $0.0162

Valuation

Market Cap: $584k
Enterprise Value: $-163k
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-14M
Revenue: $1.2M
Net Income: $-12M
Cash: $12M
Debt: $525k

Events

EarningsAug 18

EPS est. -0.97